Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice - Test2 - elhamkhani - TriplyDB

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

http://www.wikidata.org/entity/Q21144657

about

Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals Preexposure chemoprophylaxis for HIV prevention in men who have sex with men The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Rectal pre-exposure prophylaxis (PrEP)Studies of retroviral infection in humanized mice Advances in HIV microbicide development Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice New generation humanized mice for virus research: comparative aspects and future prospects Microbicides: a new hope for HIV prevention Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission A humanized mouse model of tuberculosis Electron tomography of HIV-1 infection in gut-associated lymphoid tissue Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice Targeted cytotoxic therapy kills persisting HIV infected cells during ART Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix.HIV-prevention science at a crossroads: advances in reducing sexual risk.HIV Prevention: The Key to Ending AIDS by 2030.Eradication therapies for HIV Infection: time to begin again.Animal models for HIV/AIDS research Can the new humanized mouse model give HIV research a boost The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Can a topical microbicide prevent rectal HIV transmission?Targeting Trojan Horse leukocytes for HIV prevention.IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo Current advances in humanized mouse models.Human allograft rejection in humanized mice: a historical perspective Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells

P2860

Q21131400-EEF33A58-14CC-4BF5-BB00-2EDD468B6D87 Q21559398-4FF27E02-DAAE-456A-9B1F-170EF4B9E388 Q24201955-96696D6B-16ED-436D-A015-E7AA2977EAD1 Q24612082-25B79C20-762C-4120-B43D-338C04A2C8CD Q24655011-5FA1DFA2-CCEE-465E-BD6B-80535C5F723C Q26777022-170212E2-AE28-4E52-9CCF-E735FCA45001 Q26829713-A6A816AA-738A-4DD8-BF2A-7DC25D436781 Q26849806-EACD8DAA-D1A7-4830-BD75-EA3175572481 Q26852858-6E56AAF9-0D75-4EC7-8E6C-BAAF7FDA481D Q27008307-304D28C6-5750-4741-9133-35847EB9532A Q27014786-AFECDB11-1E47-4F81-8DBA-E24E93780F36 Q27022779-141C772B-9DB2-49D6-B99A-65BE22E0AD8A Q27315009-8342F81D-622D-459C-A563-D0EB1D7E706D Q27318354-117DED43-53BE-43C6-A095-43A2BBC8EBC1 Q27320865-3E9B2A77-E6FD-4A95-8533-6FB95EDCB168 Q27331060-35A52246-498E-49D3-91E4-5B52B8FB9BCB Q27678352-83F9AD11-F7D5-4CEC-BBD7-0B40146937DB Q27692578-D809241F-E463-48D5-9CE7-2BD4CB21EAD0 Q28260539-C297659F-16D3-47C9-B086-7D34F82B019F Q28472590-D7FE90B8-311A-4E8D-85CE-A4508A66B7BB Q28474086-510903BC-94BA-4D18-818A-6BBBE2829995 Q28478394-1225587E-2CF3-4E3F-B5AD-1BD8563669F6 Q28481520-99056629-62B6-4F65-83CC-109ADEFA7E83 Q28488527-721CAF19-91F7-4B24-A35F-F4907E125D1E Q28538598-3BC6207B-776A-4602-AA5E-A2FDE7DF4C87 Q28552730-3767B0E3-6462-49A3-ACE3-21DF9BF67E70 Q30009533-38B9921E-141E-4B18-9773-E04673D4B0D4 Q30010085-FA5B54D9-931A-40F9-A76E-8374E2820705 Q30378142-0FC7113A-DD2B-426F-9320-B204F87F5505 Q30383177-4AAA0F52-2592-4581-865C-7908D1642DE7 Q30399588-B0CAB7E5-F341-4FC4-9FFF-1F8C9667EB09 Q30423656-3A1FE94D-3A1A-4516-82C9-98CAB41FE8A7 Q33315029-72FE6F03-A6D7-490A-85EC-2430F7390BC5 Q33332191-235F80E5-A959-4C71-A1C2-3A6EF68028A8 Q33358267-C55BA735-6F8E-403D-9D2D-90A1748DF099 Q33518390-BA3CFC2A-D6DF-439E-9459-B5744B025F03 Q33533290-5374BD2A-8B69-4325-9EF8-3D191CAF6615 Q33577361-B1C228FA-BB9A-4E2E-912C-74FFF01D962D Q33577374-83482F72-6C96-439C-88E9-2618CD07D51D Q33613769-D8E79CB8-D4E3-4B9D-99DF-6865B0BA7A62

P2860

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

http://www.wikidata.org/entity/Q21144657

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@ast

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en-gb

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@nl

type

label

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@ast

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en-gb

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@nl

altLabel

Antiretroviral Pre-exposure Pr ...... of HIV-1 in Humanized BLT Mice

@en

prefLabel

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@ast

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en-gb

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@nl

P1433

Q21144657-58E02B1E-D999-4449-ACFB-F89EC3E54DB3

P1476

Q21144657-2129A4FE-E650-40A0-8F34-42CC2EB57F67

P2093

Q21144657-0522E63B-AB7F-4F7F-96AA-2729EF8F52B7

Q21144657-3FF0F638-3211-4F8A-9FF2-0BEB93B1F520

Q21144657-A6C7C0C9-B21D-4081-98DD-650FC3563DF4

Q21144657-AFF02F29-4E81-4B9A-A337-E5B17DBB32ED

Q21144657-C8C18A48-B0B0-4321-8F67-641F5818A2FA

Q21144657-D36ACD9D-3C17-4F1E-B4EF-6ED2F8008035

Q21144657-D6CEC6A4-16AE-4828-B82D-CBB7868DDDC7

Q21144657-DC3B4CDA-7AD2-4E9B-8A27-8C98AB82DD3B

P2860

Q21144657-01DCAD15-9150-4A1A-A286-3EFA12B5828D

Q21144657-02981814-F747-478C-A147-F8BB406268D5

Q21144657-02C9C6B7-1C4C-4AF0-A0FC-6D5ACB0CA99D

Q21144657-03FCF916-0B7C-44D1-8AA9-E007EC2A292F

Q21144657-06920C09-8A6D-4DAA-BA33-2188D159D7AC

Q21144657-0A01A4C6-9977-480D-AE5A-75589297B047

Q21144657-10D96935-E14E-4E08-9212-2983BEA4CCAD

Q21144657-13B7D3EF-A51C-4F7E-8F05-49DA4270A288

Q21144657-14F941DB-9537-4663-BAA2-CD553391642A

Q21144657-15615838-D44E-4473-B87B-D2FE00E34254

P304

Q21144657-5D01D3AA-E217-4120-A873-5E0223FDF156

P31

Q21144657-739A10B8-D0BC-4993-88AF-AC9EB9E0F62E

P3181

Q21144657-006FD7B9-80A0-4E6E-A273-2A2A1E02F440

P356

Q21144657-6FA68EDA-B0D0-4F75-972E-FD8E5913F9FB

P407

Q21144657-01A7A3E2-BAE4-4E17-A8A4-76D2089C8ECF

P433

Q21144657-A5B56DA9-880F-452C-9980-0C1D6C4FB38E

P478

Q21144657-6994FAF0-1872-4B01-B791-8C41F54520ED

P50

Q21144657-5B11ADDC-60B4-45E1-8355-92466AB21458

Q21144657-919276BB-9888-41B8-9686-44CF657902F6

P577

Q21144657-50678481-B91D-4E04-8146-A12477AFD4A4

P5875

Q21144657-EE0B5628-1FEB-4257-B8C1-960333AD581E

P698

Q21144657-5E36A211-061E-41A3-ADFB-164E09DE1F76

P921

Q21144657-55CE1EC3-EDD3-49B5-A2C3-27A664714C29

Q21144657-B08E4464-4CD6-4ACE-AF02-6F43900A5738

Q21144657-FF1E26C7-FFB6-481A-9C57-62798AC444A1

P932

Q21144657-8DC1BBC6-1157-4FEE-B274-4A2AD35C2074

P3181

P356

JOURNAL.PMED.0050016

P1433

P1476

Antiretroviral pre-exposure pr ...... of HIV-1 in humanized BLT mice

@en

P2093

Anja K Wege

http://www.w3.org/2001/XMLSchema#string

Ashley T Haase

http://www.w3.org/2001/XMLSchema#string

Bangdong L Wei

http://www.w3.org/2001/XMLSchema#string

Deborah Payne

http://www.w3.org/2001/XMLSchema#string

Florence A Othieno

http://www.w3.org/2001/XMLSchema#string

J Victor Garcia

http://www.w3.org/2001/XMLSchema#string

Jacob D Estes

http://www.w3.org/2001/XMLSchema#string

Zhifeng Sun

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?

Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus

Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

P304

e16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1455236

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0050016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A Powell

P577

2008-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5652517

http://www.w3.org/2001/XMLSchema#string

P698

18198941

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

antiretroviral drug

P932

2194746

http://www.w3.org/2001/XMLSchema#string